CSCO
60
-7
ES
29
-26
CVS
58
-14
AON
75
2
DGX
44
-20
DOW
35
-29
CMCSA
53
-10
CTSH
45
-12
AAL
24
-2
EQT
54
-11
FLR
42
-6
DHR
50
-20
CRM
39
-28
BEN
34
-2
CMG
44
-30
ECL
42
-28
CPB
47
-17
CNX
59
-14
AME
51
-3
DIS
69
-13
CSCO
60
-7
ES
29
-26
CVS
58
-14
AON
75
2
DGX
44
-20
DOW
35
-29
CMCSA
53
-10
CTSH
45
-12
AAL
24
-2
EQT
54
-11
FLR
42
-6
DHR
50
-20
CRM
39
-28
BEN
34
-2
CMG
44
-30
ECL
42
-28
CPB
47
-17
CNX
59
-14
AME
51
-3
DIS
69
-13
Financhill
Back

Cara Therapeutics Stock Price Chart

Meet the Founder that's Revolutionizing Smartphones

This is a paid advertisement for Mode Mobile Regulation A offering. Please read the offering circular and related risks at invest.modemobile.com.
Sell
36

CARA
Cara Therapeutics

Last Price:
$5.11
Seasonality Move:
-8.29%

7 Day Trial

ALL ACCESS PASS

$ 7

Why Private Investors Didn't Lose a Penny in the Market's Recent $1T Crash

This is a paid advertisement for Mode Mobile Regulation A offering. Please read the offering circular and related risks at invest.modemobile.com.
  • The current trend is moderately bullish and CARA is experiencing slight buying pressure.

Cara Therapeutics Price Chart Indicators

Moving Averages Level Buy or Sell
8-day SMA: 5.14 Buy
20-day SMA: 4.96 Buy
50-day SMA: 4.97 Buy
200-day SMA: 4.27 Buy
8-day EMA: 5.11 Buy
20-day EMA: 5.03 Buy
50-day EMA: 4.87 Buy
200-day EMA: 6.39 Sell

Cara Therapeutics Technical Analysis Indicators

Chart Indicators Level Buy or Sell
MACD (12, 26): 0.06 Buy
Relative Strength Index (14 RSI): 55.31 Buy
Chaikin Money Flow: 1769 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (4.77 - 5.25) Buy
Bollinger Bands (100): (3.59 - 5.21) Buy

Cara Therapeutics Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):

Technical Analysis for Cara Therapeutics Stock

Is Cara Therapeutics Stock a Buy?

  • Cara Therapeutics share price is 5.15 while CARA 8-day simple moving average is 5.14, which is a Buy signal.
  • The stock price of CARA is 5.15 while Cara Therapeutics 20-day SMA is 4.96, which makes it a Buy.
  • Cara Therapeutics 50-day simple moving average is 4.97 while CARA share price is 5.15, making it a Buy technically.
  • CARA stock price is 5.15 and Cara Therapeutics 200-day simple moving average is 4.27, creating a Buy signal.

CARA Technical Analysis vs Fundamental Analysis

Sell
36
Cara Therapeutics (CARA) is a Sell

Is Cara Therapeutics a Buy or a Sell?

  • Cara Therapeutics stock is rated a Sell
    The current Cara Therapeutics [CARA] share price is $5.15. The Score for CARA is 36, which is 28% below its historic median score of 50, and infers higher risk than normal.

Cara Therapeutics Stock Info

Market Cap:
23.6M
Price in USD:
5.15
Share Volume:
7.7K

Cara Therapeutics 52-Week Range

52-Week High:
11.52
52-Week Low:
2.71
Sell
36
Cara Therapeutics (CARA) is a Sell

Cara Therapeutics Share Price Forecast

Is Cara Therapeutics Stock a Buy?

  • Cara Therapeutics share price is 5.15 while CARA 8-day exponential moving average is 5.11, which is a Buy signal.
  • The stock price of CARA is 5.15 while Cara Therapeutics 20-day EMA is 5.03, which makes it a Buy.
  • Cara Therapeutics 50-day exponential moving average is 4.87 while CARA share price is 5.15, making it a Buy technically.
  • CARA stock price is 5.15 and Cara Therapeutics 200-day simple moving average is 6.39, creating a Sell signal.

Fundamental Analysis of Cara Therapeutics

Is Cara Therapeutics a good investment?

  • Analysts estimate an earnings increase this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, an increase this year of $0.25 per share, and a decrease next year of $0.00 per share.

Technical Analysis of Cara Therapeutics

Should I short Cara Therapeutics stock?

* Cara Therapeutics stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.